Business
SenesTech, Inc. Announces Closing of $3.95 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
PHOENIX, March 23, 2021 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest
About this update from Senestech, Inc.
[{"type":"text","content":"PHOENIX, March 23, 2021 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,975,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3.95 million. SenesTech intends to use net proceeds from the registered direct offering for working capital and general corporate purposes. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. A shelf registration statement on Form S-3 (File No. 333-225712) relating to the registered direct offering of the shares of common stock described above was filed with the Securities and Exchange Commission (“SEC”) and was declared effective on August 24, 2018. The offering of the shares of common stock was made only by means of a prospectus supplement and accompanying prospectus that forms a part of the registration statement. Electronic copies of the final prospectus supplement and the accompanying prospectus were filed with the SEC and may be obtained from H.C. Wainwright & Co., LLC, 430 Park Avenue, 3rd Floor, New York, NY 10022, by calling (646) 975-6996 or by emailing [email protected] or at the SEC’s website at http://www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About SenesTech SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pe...